North America Pharmaceutical Contract Research Organization (CRO) Market 2022-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity
- Report ID: 29911
- Date: Jun, 2022
- Pages: 132
- Category: Healthcare & Pharmaceuticals
North America pharmaceutical contract research organization (CRO) market is projected to grow by 9.0% annually in the forecast period and reach $37.61 billion by 2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 59 tables and 44 figures, this 132-page report “North America Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.
Based on Service, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services
Based on Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of North America Market by Service 44
3.1 Market Overview by Service 44
3.2 CRO for Pre-clinical Development 46
3.3 CRO for Phase I Trials 47
3.4 CRO for Phase II Trials 48
3.5 CRO for Phase III Trials 49
3.6 CRO for Phase IV Trials 50
3.7 Laboratory Services 51
3.8 Consulting Services 52
3.9 Data Management Services 53
4 Segmentation of North America Market by Therapeutic Application 54
4.1 Market Overview by Therapeutic Application 54
4.2 Infectious Diseases 56
4.3 Oncology 57
4.4 Metabolic Disorders 58
4.5 Cardiovascular Disorders 59
4.6 Central Nervous System 60
4.7 Respiratory Disorders 61
4.8 Gastrointestinal Disorders 62
4.9 Other Therapeutic Applications 63
5 Segmentation of North America Market by End User 64
5.1 Market Overview by End User 64
5.2 Pharmaceutical & Biopharmaceutical Companies 66
5.3 Medical Device Companies 67
5.4 Academic Institutes 68
6 North America Market 2019-2030 by Country 69
6.1 Overview of North America Market 69
6.2 U.S. 72
6.3 Canada 75
6.4 Mexico 77
7 Competitive Landscape 79
7.1 Overview of Key Vendors 79
7.2 New Product Launch, Partnership, Investment, and M&A 83
7.3 Company Profiles 84
Charles River Laboratories 84
CMIC Co. Ltd 86
Covance Inc. 88
Hangzhou Tigermed Consulting Co., Ltd. 92
ICON Plc 95
IQVIA Holdings Inc. 98
LSK North America Pharma Service Co., Ltd. 102
Novotech Pty Ltd 104
PAREXEL International Corporation 106
Pharmaceutical Product Development LLC (PPD) 110
PRA Health Sciences Inc. 112
Quanticate Ltd 114
Samsung Bioepis Co., Ltd. 116
SGS SA (SGS Life Sciences) 118
Syneos Health Inc. 121
WuXi AppTec Inc. 124
8 Investing in North America Market: Risk Assessment and Management 126
8.1 Risk Evaluation of North America Market 126
8.2 Critical Success Factors (CSFs) 129
Related Reports and Products 132
List of Tables
Table 1. Snapshot of North America Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27
Table 4. Worldwide Total Number of Registered Clinical Trials 29
Table 5. World Health Spending by Region, $ bn, 2013-2020 32
Table 6. Main Product Trends and Market Opportunities in North America Pharmaceutical CRO Market 36
Table 7. North America Pharmaceutical CRO Market by Service, 2019-2030, $ bn 44
Table 8. North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 54
Table 9. North America Pharmaceutical CRO Market by End User, 2019-2030, $ bn 64
Table 10. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn 70
Table 11. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn 74
Table 12. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 74
Table 13. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn 74
Table 14. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn 76
Table 15. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 76
Table 16. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn 76
Table 17. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn 78
Table 18. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 78
Table 19. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn 78
Table 20. Breakdown of World Market by Key Vendor, 2020, % 81
Table 21. Charles River Laboratories: Company Snapshot 84
Table 22. Charles River Laboratories: Product Portfolio 85
Table 23. CMIC Co. Ltd.: Company Snapshot 86
Table 24. CMIC Co. Ltd.: Business Segmentation 87
Table 25. CMIC Co. Ltd.: Revenue by Region, 2018, % 87
Table 26. Covance Inc.: Company Snapshot 88
Table 27. Covance Inc.: Product Portfolio 89
Table 28. Covance Inc.: Revenue by Region, 2020, % 90
Table 29. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot 92
Table 30. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation 93
Table 31. ICON Plc: Company Snapshot 95
Table 32. ICON Plc: Business Segmentation 95
Table 33. ICON Plc: Product Portfolio 96
Table 34. ICON Plc: Revenue by Region, 2020, % 96
Table 35. IQVIA Holdings Inc.: Company Snapshot 98
Table 36. IQVIA Holdings Inc.: Business Segmentation 99
Table 37. IQVIA Holdings Inc.: Revenue by Region, 2020, % 99
Table 38. IQVIA Holdings Inc.: Product Portfolio 100
Table 39. LSK North America Pharma Service Co., Ltd.: Company Snapshot 102
Table 40. Novotech Pty Ltd: Company Snapshot 104
Table 41. PAREXEL International Corporation: Company Snapshot 106
Table 42. PAREXEL International Corporation: Business Segmentation 107
Table 43. PAREXEL International Corporation: Revenue by Region, 2018, % 107
Table 44. PAREXEL International Corporation: Product Portfolio 108
Table 45. Pharmaceutical Product Development LLC (PPD): Company Snapshot 110
Table 46. PRA Health Sciences Inc.: Company Snapshot 112
Table 47. PRA Health Sciences Inc.: Business Segmentation 113
Table 48. PRA Health Sciences Inc.: Revenue by Region, 2018, % 113
Table 49. Quanticate Ltd: Company Snapshot 114
Table 50. Samsung Bioepis Co., Ltd.: Company Snapshot 116
Table 51. SGS SA (SGS Life Sciences): Company Snapshot 118
Table 52. SGS SA (SGS Life Sciences): Business Segmentation 119
Table 53. SGS SA (SGS Life Sciences): Revenue by Region, 2018, % 119
Table 54. Syneos Health Inc.: Company Snapshot 121
Table 55. Syneos Health Inc.: Business Segmentation 122
Table 56. Syneos Health Inc.: Revenue by Region, 2018, % 122
Table 57. WuXi AppTec Inc.: Company Snapshot 124
Table 58. Risk Evaluation for Investing in North America Market, 2021-2030 127
Table 59. Critical Success Factors and Key Takeaways 130
List of Figures
Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030 17
Figure 5. North America Pharmaceutical CRO Market, 2019-2030, $ bn 20
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical CRO Market 25
Figure 8. Leading Causes of Death in the World, 2019-2020, million 30
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 31
Figure 11. Primary Restraints and Impact Factors of North America Pharmaceutical CRO Market 33
Figure 12. Investment Opportunity Analysis 37
Figure 13. Porter’s Fiver Forces Analysis of North America Pharmaceutical CRO Market 40
Figure 14. Breakdown of North America Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 45
Figure 15. North America Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%) 45
Figure 16. North America Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 46
Figure 17. North America Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 47
Figure 18. North America Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 48
Figure 19. North America Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 49
Figure 20. North America Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 50
Figure 21. North America Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 51
Figure 22. North America Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 52
Figure 23. North America Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 53
Figure 24. Breakdown of North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 55
Figure 25. North America Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%) 55
Figure 26. North America Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 56
Figure 27. North America Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 57
Figure 28. North America Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 58
Figure 29. North America Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 59
Figure 30. North America Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 60
Figure 31. North America Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 61
Figure 32. North America Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 62
Figure 33. North America Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 63
Figure 34. Breakdown of North America Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 65
Figure 35. North America Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%) 65
Figure 36. North America Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 66
Figure 37. North America Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 67
Figure 38. North America Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 68
Figure 39. Breakdown of North America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 70
Figure 40. Contribution to North America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 71
Figure 41. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn 73
Figure 42. Canada Pharmaceutical CRO Market, 2019-2030, $ bn 75
Figure 43. Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn 77
Figure 44. Growth Stage of North America Pharmaceutical CRO Industry over the Forecast Period 79
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
